IBRX insider buying and SEC filings, explained
ImmunityBio, Inc. · CIK 1326110
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$9.5M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 5, 2026 | Planned (10b5-1) | Barry J. Simon (Director) sold 25,000 shares at about $10.75 ($269K), marked as a 10b5-1 plan trade. Holdings down 1% to 2,777,788 shares. | SEC filing Filed Oct 6, 2026, 6:06 PM ET |
| Oct 2, 2026 | Planned (10b5-1) | Cheryl Cohen (Director) sold 81,056 shares at $10.50 ($851K), marked as a 10b5-1 plan trade. Holdings down 45% to 100,309 shares. | SEC filing Filed Oct 6, 2026, 6:05 PM ET |
| Jul 2, 2026 | Planned (10b5-1) | Cheryl Cohen (Director) sold 131,210 shares at about $9.50 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 51% to 125,386 shares. | SEC filing Filed Jul 6, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Christobel Selecky (Director) sold 159,478 shares at about $9.02 ($1.4M), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 6, 2026 |
| Jun 29–30, 2026 | Planned (10b5-1) | Christobel Selecky (Director) sold 96,722 shares between Jun 29 and Jun 30 at about $9.01 ($871K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jul 1, 2026 |
| Jun 24, 2026 | Planned (10b5-1) | Barry J. Simon (Director) sold 25,000 shares at about $7.88 ($197K), marked as a 10b5-1 plan trade. Holdings down 1% to 2,802,788 shares. | SEC filing Filed Jun 26, 2026 |
| Jun 4, 2026 | Planned (10b5-1) | Barry J. Simon (Director) sold 23,033 shares at about $7.18 ($165K), marked as a 10b5-1 plan trade. Holdings down 1% to 2,827,788 shares. | SEC filing Filed Jun 5, 2026 |
| Feb 24, 2026 | Planned (10b5-1) | Barry J. Simon (Director) sold 75,000 shares at about $12.01 ($901K), marked as a 10b5-1 plan trade. Holdings down 3% to 2,850,821 shares. | SEC filing Filed Feb 26, 2026 |
| Feb 23, 2026 | Planned (10b5-1) | Christobel Selecky (Director) sold 25,000 shares at $10.00 ($250K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Feb 24, 2026 |
| Feb 20–23, 2026 | Planned (10b5-1) | Barry J. Simon (Director) sold 175,000 shares between Feb 20 and Feb 23 at about $10.19 ($1.8M), marked as a 10b5-1 plan trade. Holdings down 6% to 2,925,821 shares. | SEC filing Filed Feb 24, 2026 |
| Jan 20, 2026 | Planned (10b5-1) | Barry J. Simon (Director) sold 151,967 shares at about $7.20 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 5% to 3,091,604 shares. | SEC filing Filed Jan 21, 2026 |
| Jan 16–20, 2026 | Planned (10b5-1) | Christobel Selecky (Director) sold 75,000 shares between Jan 16 and Jan 20 at about $5.84 ($438K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jan 21, 2026 |
25 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow IBRX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.